Literature DB >> 56417

Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates.

L Cohen, R S Holzman, F T Valentine, H S Lawrence.   

Abstract

After our initial report tha leukocyte dialysates containing transfer factor augment the thymidine incorporation of antigen-stimulated lymphocytes, we have adapted the system to microleukocyte cultures. This modification permits both (a) the simultaneous assay of a single dialysate on the cells of multiple individuals, and (b) the assay of multiple dialysates on the cells of a single individual. The data thus secured, demonstrate that dialysates from both skin-test-positive and -negative donors produced similar degrees of augmentation whether the data are expressed as an arithmetic difference or as a ratio. When expressed as an arithmetic difference, the amount of augmentation is increased in proportion to the level of thymidine incorporation of the assay cells when they were stimulated by antigen alone. When expressed as a ratio, however, the degree of augmentation is independent of the response of the assay cells. An analysis of the ability of dialysates to engage previously uncommitted lymphocytes and thus to augment thymidine incorporation, revealed that precommitted cells were required. In these experiments, antigen-reactive cells were deleted from populations of peripheral blood lymphocytes by incubation with purified protein derivative of tuberculin, diphtheria toxoid, or streptokinase-streptodornase in the presence of [3H]thymidine of high specific activity. This deletion depressed or abolished the effect of dialysate on the residual population when it was recultured with the same antigen, but the effect on the response of the remaining lymphocytes to other antigens was unaltered. In this study, leukocyte dialysate appeared to augment nonspecifically the thymidine incorporation of an antigen-specific precommitted clone of lymphocytes. The relationship of these adjuvant effects on peripheral blood lymphocytes in vitro to the specific and nonspecific activities of transfer factor in vivo remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56417      PMCID: PMC2190153          DOI: 10.1084/jem.143.4.791

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Augmentation of PPD- and LPS-induced T-independent DNA synthesis in normal mouse spleen cells by leukocyte lysates from tuberculosis patients.

Authors:  D W Palmer; R T Smith
Journal:  Cell Immunol       Date:  1974-08       Impact factor: 4.868

Review 2.  Transfer factor in cellular immunity.

Authors:  H S Lawrence
Journal:  Harvey Lect       Date:  1974

3.  Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells.

Authors:  J Watson; R Epstein; M Cohn
Journal:  Nature       Date:  1973-12-14       Impact factor: 49.962

4.  In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity.

Authors:  L J Brandes; G J Goldenberg
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

5.  The PHA dose-response curve: validation of the use of logarithmic graph paper by computer analysis results.

Authors:  J B Ziegler; P J Hansen; W A Davies; R Penny
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  In vitro properties of leukocyte dialysates containing transfer factor.

Authors:  M S Ascher; W J Schneider; F T Valentine; H S Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Transfer factor in vitro. Additional data concerning a new method.

Authors:  M Arala-Chaves; M T Ramos; R Rosado; P Branco
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

Review 8.  Transfer factor.

Authors:  H S Lawrence
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

9.  Cellular interactions in the leukocyte migration inhibition system.

Authors:  S E Read; J B Zabriskie
Journal:  Transplant Proc       Date:  1972-06       Impact factor: 1.066

10.  A suppression of cellular immunity in patients with multiple sclerosis.

Authors:  V Utermohlen; J B Zabriskie
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  1 in total

1.  An investigation into the antigen-specificity of transfer factor in its stimulatory action on lymphocyte transformation.

Authors:  M R Salaman
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.